Kenneth Burhop
Director/Miembro de la Junta en OptMed, Inc. .
Cargos activos de Kenneth Burhop
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Director/Miembro de la Junta | 01/05/2022 | - |
Independent Dir/Board Member | 01/05/2022 | - |
Historial de carrera de Kenneth Burhop
Antiguos cargos conocidos de Kenneth Burhop.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/02/2011 | 01/10/2013 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Director Técnico/Científico/I+D | 01/01/1986 | - |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - | - |
INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Director Técnico/Científico/I+D | 26/02/2014 | - |
Formación de Kenneth Burhop.
University of Wisconsin | Doctorate Degree |
University of Wisconsin-Milwaukee | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Kenneth Burhop
- Experiencia